Article Information
History
- December 22, 2017.
Article Versions
- Version 1 (December 2, 2017 - 06:45).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Charlotte M de Winde1,2,
- Alexandra L Matthews3,*,
- Sjoerd van Deventer1,*,
- Alie van der Schaaf1,
- Neil D Tomlinson4,
- Erik Jansen1,
- Johannes A Eble5,
- Bernhard Nieswandt6,
- Helen M McGettrick7,
- Carl G Figdor1,
- Sophie E Acton2,#,
- Michael G Tomlinson3,8,# and
- Annemiek B van Spriel1,$
- 1Radboud university medical center, Radboud Institute for Molecular Life Sciences, Department of Tumor Immunology, Nijmegen, The Netherlands.
- 2MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom.
- 3School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
- 4Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
- 5Institute for Physiological Chemistry and Pathobiochemistry, Münster, Germany.
- 6University Clinic of Würzburg & Rudolf Virchow Center, Würzburg, Germany.
- 7Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
- 8Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Midlands, United Kingdom.
- ↵$ Corresponding author; annemiek.vanspriel{at}radboudumc.nl
↵*# Authors contributed equally to the work